QELBREE 200 mg/1

QELBREE 200 mg is an extended-release capsule containing viloxazine hydrochloride, used for managing certain conditions. This medication is designed for oral administration and is manufactured by Supernus Pharmaceuticals, Inc.

QELBREE 200 mg is primarily used for managing symptoms associated with specific conditions. Viloxazine hydrochloride, the active ingredient, works to support overall well-being. This medication is often prescribed to help improve daily functioning and quality of life.

Common effects of QELBREE 200 mg may include changes in mood, energy levels, and overall sense of well-being. Some users may experience mild gastrointestinal discomfort or sleep disturbances. These effects can vary widely among individuals.

QELBREE 200 mg should be handled with care and stored properly to maintain its effectiveness. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid sudden discontinuation without consulting a healthcare provider.

QELBREE 200 mg may interact with certain substances, including alcohol and other medications. It is advisable to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.